Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Current Leases (2019 - 2024)

Serina Therapeutics' Current Leases history spans 4 years, with the latest figure at $11000.0 for Q2 2024.

  • For Q2 2024, Current Leases changed N/A year-over-year to $11000.0; the TTM value through Jun 2024 reached $11000.0, changed N/A, while the annual FY2023 figure was $214000.0, N/A changed from the prior year.
  • Current Leases for Q2 2024 was $11000.0 at Serina Therapeutics, down from $214000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $325000.0 in Q1 2020 and bottomed at $11000.0 in Q2 2024.
  • The 3-year median for Current Leases is $161500.0 (2020), against an average of $164750.0.
  • The largest YoY upside for Current Leases was 73.86% in 2020 against a maximum downside of 73.86% in 2020.
  • A 3-year view of Current Leases shows it stood at $109000.0 in 2020, then skyrocketed by 96.33% to $214000.0 in 2023, then crashed by 94.86% to $11000.0 in 2024.
  • Per Business Quant, the three most recent readings for SER's Current Leases are $11000.0 (Q2 2024), $214000.0 (Q4 2023), and $109000.0 (Q3 2020).